35 reports

  • STATINS
  • INCREASING USE OF STATINS
  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC
  • STATINS
  • STATINS
  • Statins
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • SHOWS GLOBAL ACS SALES FOR GENERIC STATINS IN 2015-2025.
  • GLOBAL ACS SALES FORECASTS [$M] FOR GENERIC STATINS, 2015-2025
  • Statins
  • World
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • 05/04/2016: Esperion Therapeutics Provides Bempedoic Acid Development Program Updates
  • 08/04/2016: Esperion Therapeutics Provides Bempedoic Acid Development Program Update
  • Statins
  • Therapy
  • United States
  • Company
  • Esperion Therapeutics, Inc.
  • MAY 04, 2016: ESPERION THERAPEUTICS PROVIDES BEMPEDOIC ACID DEVELOPMENT PROGRAM UPDATES
  • ARI-3037MO - DRUG PROFILE
  • Cholesterol
  • Obesity
  • Pharmaceutical
  • Statins
  • Esperion Therapeutics, Inc.
  • Mar 27, 2007: Merck And Schering To Develop Zetia/Lipitor Combo As Focus On Reducing Bad Cholesterol Returns
  • May 03, 2013: Merck Gets FDA Approval For Liptruzeta For Treatment Of Primary Or Mixed Hyperlipidemia
  • Statins
  • South Korea
  • United States
  • World
  • Product Initiative
  • Mar 27, 2007: Merck And Schering To Develop Zetia/Lipitor Combo As Focus On Reducing Bad Cholesterol Returns
  • May 03, 2013: Merck Gets FDA Approval For Liptruzeta For Treatment Of Primary Or Mixed Hyperlipidemia
  • Lipid Modifying Drug
  • Statins
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • Clinical Trial profile. 496 Trial Title
  • Target
  • Cardiovascular Disease
  • Lipid Modifying Drug
  • Pharmaceutical
  • Statins
  • World
  • Oct 13, 2016: Bempedoic Acid Global Phase 3 Clinical Program to Include Patients on Any Statin at Any Dose
  • Aug 04, 2016: Esperion Therapeutics Provides Bempedoic Acid Development Program Update
  • Endocrine Disease
  • Statins
  • United States
  • Company
  • Product Initiative
  • Target
  • Clinical Trial profile. 334 Trial Title
  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World
  • Clinical Trial profile. 287 Trial Title
  • Mar 18, 2017: No Benefit of Synthetic HDL-C on Arterial Plaque

In the E. U., Praluent is approved for the treatment of adult patients with primary hypercholesterolemia (HeFH and non-familial) or mixed dyslipidemia as an adjunct to diet: a) in combination with a statin, or statin with other lipid-lowering therapies in patients unable to reach th

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World
  • Clinical Trial profile. 25 Trial Title
  • Clinical Trial profile. 17 Trial Title
  • Cardiovascular Disease
  • Chronic Disease
  • Pharmaceutical
  • Statins
  • World
  • Target

Statin Monotherapy and Statin-fibrate Combination Therapy in Patients with Elevated Triglycerides and LDL-cholesterol on Progression of Atherosclerotic Plaques, Endothelial Function, and Markers for Anti-inflammatory Properties/ obesity/ antioxidative Properties Prospective

  • Cardiology
  • Clinical Trial
  • Hospital
  • Statins
  • World
  • 5. All the trials included are unique trials.

CORONARY DISEASE THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2017* CORONARY DISEASE THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2017* aspirin and undisclosed statin alone or in combination has the highest number of coronary disease ongoing clinical trials

  • Clinical Trial
  • Drug Discovery And Development
  • Statins
  • World
  • Merck & Co., Inc.
  • CRESTOR (ROSUVASTATIN) SWOT ANALYSIS, 2014
  • ZOCOR (SIMVASTATIN) SWOT ANALYSIS, 2014
  • Statins
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • most common adverse events (AEs) in this trial were nasopharyngitis, injection-site reaction and headache.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • Endocrine Disease
  • Statins
  • United States
  • Company
  • Product Initiative
  • Clinical Trial profile. 147 Trial Title
  • Clinical Trial profile. 131 Trial Title
  • Angina
  • Cardiovascular Drug
  • Statins
  • World
  • Product Initiative

Statin Therapy (LOW) Study The Low HDL on Six Weeks Statin Therapy (LOW) Study GDCT## NCT##, 2004-##-##; v##; EudraCT-2004-##-## Cardiovascular Coronary Arteriosclerosis, Dyslipidemia (C Reactive Protein (Pentraxin ## or CRP), High Density Lipoprotein Cholesterol (H

  • Cardiovascular Disease
  • Statins
  • World
  • Product Initiative
  • Pfizer Inc.
  • Target
  • Clinical Trial profile. 15 Trial Title
  • Cardiology
  • Statins
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 522 Trial Title
  • Clinical Trial profile. 114 Trial Title
  • Cardiovascular Disease
  • Clinical Trial
  • Statins
  • World
  • Merck & Co., Inc.
  • Clinical Trial profile. 12 Trial Title
  • Clinical Trial profile. 480 Trial Title
  • Acute Coronary Syndrome
  • Cardiovascular Disease
  • Clinical Trial
  • Statins
  • AstraZeneca PLC
  • EFFECTS ON INSULIN, HSCRP AND BLOOD PRESSURE.
  • May 11, 2016: Cigna's New Value-Based Contract with Amgen for Repatha
  • Chronic Disease
  • Statins
  • United States
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Statins on Inflammatory Markers of Athersclerotic Tissue GDCT## NCT##, ##-##; Merck 02005 Cardiovascular Atherosclerosis, Carotid Artery Stenosis, Inflammation Completed Phase I Interventional simvastatin Mayo Clinic Merck & Co Inc ## Sep 2002 ## Mar 2006 ## ## ## ## Hydroxy ##

  • Cardiology
  • Statins
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 117 Trial Title

Statin Therapy with Attained Low-density Lipoprotein Cholesterol Based Statin Therapy in Patients with Coronary Artery Disease: Statin Strategy Proposal Trial Comparing the Intensity-based Statin Therapy with Attained Low-density Lipoprotein Cholesterol Based

  • Angina
  • Cardiovascular Drug
  • Statins
  • World
  • Product Initiative

Statin for Coronary Plaque Modification Statin and Atheroma Vulnerability Evaluation (STABLE) GDCT## NCT##, 2008-## Cardiovascular Acute Coronary Syndrome, Artery Stenosis, Atherosclerosis, Coronary Artery Disease (CAD) (Ischemic Heart Disease), Coronary Stenosis Compl

  • Clinical Trial
  • Drug Discovery And Development
  • Statins
  • World
  • Product Initiative
  • Clinical Trial profile. 49 Trial Title
  • Clinical Trial profile. 532 Trial Title
  • Cardiovascular Disease
  • Clinical Trial
  • Drug Discovery And Development
  • Statins
  • World
  • Official Title
  • Lipid Modifying Drug
  • Pharmaceutical
  • Statins
  • World
  • Product Initiative
  • Clinical Trial profile. 440 Trial Title
  • Clinical Trial profile. 444 Trial Title
  • Acute Coronary Syndrome
  • Cardiovascular Disease
  • Clinical Trial
  • Statins
  • AstraZeneca PLC
  • Clinical Trial profile. 500 Trial Title
  • Clinical Trial profile. 135 Trial Title
  • Cardiovascular Disease
  • Clinical Trial
  • Statins
  • World
  • Merck & Co., Inc.
  • EVOLOCUMAB - DRUG PROFILE
  • May 04, 2016: Esperion Therapeutics Provides Bempedoic Acid Development Program Updates
  • Lipid Modifying Drug
  • Statins
  • United States
  • Company
  • Product Initiative